Form 4 for BMY Bristol Myers Squibb
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-01 · accession 0000014272-25-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-04 | 2025-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +10.1K | 10.9K | +1,292% | $0 |
| D | 2025-02-04 | 2025-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $58.95 | -3,725 | 7,133 | -34% | -$219.6K |
| D | 2025-02-04 | 2025-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | -10.1K | 20.2K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2025-02-01 | M | A | 10,078 | $0.00 | 10,858 | D | — | — | (F1) The restricted stock units vest in three equal installments beginning on February 1, 2025. |
| 2 | Common | Common Stock, $0.10 par value | 2025-02-01 | F | D | 3,725 | $58.95 | 7,133 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of award. |
| 3 | Derivative | Restricted Stock Units | 2025-02-01 | M | D | 10,078 | $0.00 | 20,158 | D | — · — to 2027-02-01 | 10,078 Common Stock, $0.10 par value | (F3) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock units vest in three equal installments beginning on February 1, 2025. |